These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15319748)

  • 1. [Contribution of large clinical studies to daily practices].
    Bron A
    J Fr Ophtalmol; 2004 Jun; 27(6 Pt 2):689-92. PubMed ID: 15319748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
    Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
    Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment.
    Katz J; Congdon N; Friedman DS
    Arch Ophthalmol; 1999 Sep; 117(9):1137-42. PubMed ID: 10496384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of 8 prospective, randomized, multicenter glaucoma trials.
    Panarelli JF; Banitt MR; Sidoti PA; Budenz DL; Singh K
    J Glaucoma; 2015 Jan; 24(1):64-8. PubMed ID: 23632410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment.
    Katz J
    Ophthalmology; 1999 Feb; 106(2):391-5. PubMed ID: 9951496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ocular hypertension and glaucoma: the contribution of large studies to daily practice].
    Bron A
    J Fr Ophtalmol; 2002 Jun; 25(6):641-54. PubMed ID: 12223955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Update on prospective glaucoma intervention studies].
    Arend KO; Redbrake C
    Klin Monbl Augenheilkd; 2005 Oct; 222(10):807-13. PubMed ID: 16240274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of glaucoma progression by perimetry and optic disc photography at different stages of the disease: results from the Early Manifest Glaucoma Trial.
    Öhnell H; Heijl A; Anderson H; Bengtsson B
    Acta Ophthalmol; 2017 May; 95(3):281-287. PubMed ID: 27778463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Manifest Glaucoma Trial: design and baseline data.
    Leske MC; Heijl A; Hyman L; Bengtsson B
    Ophthalmology; 1999 Nov; 106(11):2144-53. PubMed ID: 10571351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ocular Hypertension Treatment Study: design and baseline description of the participants.
    Gordon MO; Kass MA
    Arch Ophthalmol; 1999 May; 117(5):573-83. PubMed ID: 10326953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medicinal glaucoma therapy. What can we learn from large randomized clinical trials?].
    Jünemann AG; Huchzermeyer C; Rejdak R
    Ophthalmologe; 2013 Dec; 110(12):1134-48. PubMed ID: 24337205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies.
    Wilson MR; Kosoko O; Cowan CL; Sample PA; Johnson CA; Haynatzki G; Enger C; Crandall D
    Am J Ophthalmol; 2002 Sep; 134(3):399-405. PubMed ID: 12208252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of dynamic observation of patients with primary glaucoma].
    Nabiev AM
    Vestn Oftalmol; 2003; 119(2):40-1. PubMed ID: 13678010
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of Visual Field Progression in Glaucoma Patients with Progressive Retinal Nerve Fiber Layer Thinning: A 5-Year Prospective Study.
    Yu M; Lin C; Weinreb RN; Lai G; Chiu V; Leung CK
    Ophthalmology; 2016 Jun; 123(6):1201-10. PubMed ID: 27001534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study.
    Miglior S; Torri V; Zeyen T; Pfeiffer N; Vaz JC; Adamsons I;
    Am J Ophthalmol; 2007 Aug; 144(2):266-275. PubMed ID: 17543874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deterioration of visual fields in patients with glaucoma with and without optic disc hemorrhages.
    Rasker MT; van den Enden A; Bakker D; Hoyng PF
    Arch Ophthalmol; 1997 Oct; 115(10):1257-62. PubMed ID: 9338670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular Hypertension Treatment Study (OHTS) commentary.
    Lee BL; Wilson MR;
    Curr Opin Ophthalmol; 2003 Apr; 14(2):74-7. PubMed ID: 12698045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The European glaucoma prevention study design and baseline description of the participants.
    Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I;
    Ophthalmology; 2002 Sep; 109(9):1612-21. PubMed ID: 12208707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients.
    Musch DC; Lichter PR; Guire KE; Standardi CL
    Ophthalmology; 1999 Apr; 106(4):653-62. PubMed ID: 10201583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
    Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
    Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.